Polarean Imaging Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chris Von Jako

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage44.70%
CEO tenure2yrs
CEO ownership0.5%
Management average tenure4yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

author-image

Pharma Trials And Pediatric FDA Approval Will Open Global Markets

New revenue vertical in pharma-sponsored trials and FDA approval for younger patients expand market opportunities and potential revenue streams.

We're Not Very Worried About Polarean Imaging's (LON:POLX) Cash Burn Rate

Feb 05
We're Not Very Worried About Polarean Imaging's (LON:POLX) Cash Burn Rate

Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Oct 16
Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Here's Why Polarean Imaging (LON:POLX) Must Use Its Cash Wisely

Jan 09
Here's Why Polarean Imaging (LON:POLX) Must Use Its Cash Wisely

Is Polarean Imaging (LON:POLX) In A Good Position To Invest In Growth?

Sep 11
Is Polarean Imaging (LON:POLX) In A Good Position To Invest In Growth?

Is Polarean Imaging (LON:POLX) In A Good Position To Invest In Growth?

Feb 09
Is Polarean Imaging (LON:POLX) In A Good Position To Invest In Growth?

We're Keeping An Eye On Polarean Imaging's (LON:POLX) Cash Burn Rate

Oct 09
We're Keeping An Eye On Polarean Imaging's (LON:POLX) Cash Burn Rate

Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Dec 15
Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

We Think Shareholders Will Probably Be Generous With Polarean Imaging plc's (LON:POLX) CEO Compensation

Jul 07
We Think Shareholders Will Probably Be Generous With Polarean Imaging plc's (LON:POLX) CEO Compensation

Here's Why We're Watching Polarean Imaging's (LON:POLX) Cash Burn Situation

Jun 07
Here's Why We're Watching Polarean Imaging's (LON:POLX) Cash Burn Situation

Insider Buying: The Polarean Imaging plc (LON:POLX) Independent Chairman Just Bought 6.6% More Shares

Mar 18
Insider Buying: The Polarean Imaging plc (LON:POLX) Independent Chairman Just Bought 6.6% More Shares

Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Mar 09
Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Polarean Imaging (LON:POLX) Shareholders Have Enjoyed An Impressive 135% Share Price Gain

Feb 01
Polarean Imaging (LON:POLX) Shareholders Have Enjoyed An Impressive 135% Share Price Gain

Should You Take Comfort From Insider Transactions At Polarean Imaging plc (LON:POLX)?

Dec 28
Should You Take Comfort From Insider Transactions At Polarean Imaging plc (LON:POLX)?

What Type Of Shareholders Own The Most Number of Polarean Imaging plc (LON:POLX) Shares?

Nov 30
What Type Of Shareholders Own The Most Number of Polarean Imaging plc (LON:POLX) Shares?

CEO Compensation Analysis

How has Chris Von Jako's remuneration changed compared to Polarean Imaging's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024US$1mUS$530k

-US$9m

Sep 30 2024n/an/a

-US$9m

Jun 30 2024n/an/a

-US$9m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$618kUS$240k

-US$12m

Compensation vs Market: Chris's total compensation ($USD1.19M) is above average for companies of similar size in the UK market ($USD396.12K).

Compensation vs Earnings: Chris's compensation has increased whilst the company is unprofitable.


CEO

Chris Von Jako (55 yo)

2yrs
Tenure
US$1,185,771
Compensation

Dr. Christopher Richard Von Jako, also known as Chris, Ph D., serves as Chief Executive Officer and Director of Polarean Imaging plc since June 20, 2023. He serves as Board Member of nView Medical Inc. sin...


Leadership Team

NamePositionTenureCompensationOwnership
Kenneth West
Non-Executive Chairman of the Board8.1yrsUS$192.98k0.53%
£ 81.9k
Christopher Von Jako
CEO & Director2yrsUS$1.19m0.52%
£ 80.3k
Charles Osborne
CFO & Director6.2yrsUS$427.13k0.16%
£ 25.1k
Neil Wadehra
Vice President of Operationsno datano datano data
Alex Dusek
Chief Commercial Officer3.4yrsno datano data
Chase Hall
Chief Medical Advisorless than a yearno datano data
Stephen Austin
Company Secretary7.3yrsno datano data
4.0yrs
Average Tenure
58yo
Average Age

Experienced Management: POLX's management team is considered experienced (4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kenneth West
Non-Executive Chairman of the Board8.1yrsUS$192.98k0.53%
£ 81.9k
Christopher Von Jako
CEO & Director2yrsUS$1.19m0.52%
£ 80.3k
Charles Osborne
CFO & Director4.3yrsUS$427.13k0.16%
£ 25.1k
Frank Schulkes
Non-Executive Director3.2yrsUS$94.29k0.13%
£ 20.1k
Cyrille Petit
Non-Executive Director5yrsUS$91.34k0.41%
£ 62.6k
Juergen Laucht
Non-Executive Director8.1yrsUS$88.48k0.078%
£ 12.0k
Daniel Brague
Independent Non-Executive Director3.1yrsUS$91.51k0.13%
£ 20.1k
4.3yrs
Average Tenure
59yo
Average Age

Experienced Board: POLX's board of directors are considered experienced (4.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/01 11:22
End of Day Share Price 2025/05/30 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Polarean Imaging plc is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Colin SmithCapital Access Group
Christian GlennieStifel, Equities Research
null nullStifel, Equities Research